Early assessment of transplanted liver function: Lignocaine clearance test (MEGX)

European Journal of Anaesthesiology

Volumn 14, Issue 4, 1997, Pages 397-405

  Freys, G ^a   Pottecher, T ^a   Calon, B ^a   Hamel, G ^a   Pain, L ^a   Boudjema, K ^a   Otteni, J C ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Liver, function; Metabolism, lignocaine; Surgery, orthotopic transplantation, liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 5; DEETHYLLIDOCAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG CLEARANCE; DRUG TRANSFORMATION; GRAFT REJECTION; HUMAN; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PROTHROMBIN TIME; REVASCULARIZATION; TREATMENT OUTCOME;

EID: 0030803308     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199707000-00010     Document Type: Article

References (50)

1. Greig PD, Woolf GM, Abecassis M et al. Prostaglandin E1 for primary non function following liver transplantation. Transplant Proc 1989; 21: 3360-3361.
2. Ploeg RJ, D'Alessandro AM, Knechtle SJ et al. Risk factors for primary dysfunction after liver transplantation. A multivariate analysis. Transplantation 1993; 55: 807-613.
3. Taki Y, Gubernatis G, Yamaoka Y et al. Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation 1990; 49: 535-539.
4. Path JJ, Ascher NL, Konstandinides FN et al. Metabolism during hepatic transplantation. Indicators of allograft function. Surgery 1984; 96: 964-972.
5. Gubernatis G, Bornscheuer A, Taki Y et al. Total oxygen consumption, ketone body ratio and a special score as early indicators of irreversible liver allograft dysfunction. Transplantation Proc 1989; 21: 2279-2281.
6. Hickmann R, Rose-Innes C, Tyler M, Bracher M, Lotz Z, Fourie J. Energy charge as a indication of liver viability. Transplantation 1992; 53: 540-545.
7. Bresson-Hadni S, Rossel M, Seilles E et al. Serum and bile secretory immunoglobulins and secretory components during the early postoperative course after liver transplantation. Hepatology 1991; 14: 1046-1053.
8. Ericzon BG, Ensufzai S, Einarsson K, Angelin B. Biliary lipid secretion early after liver transplantation. Transplant Proc 1990; 22: 1537-1538.
9. Forster J, Yan ZY, Payne KM, Wood JG, Eisenach JB, Delcore R. Bilirubin secretion as an early indicator of patient survival following orthotopic liver transplantation. Transplant Proc 1993; 25: 1889-1890.
10. Forster J, Greig PD, Glynn MFX et al. Coagulation factors as indicators of early graft function following liver transplantation. Transplant Proc 1989; 21: 2308-2310.
11. Yokoyama I, Todo S, Miyata T, Tzakis AG, Starz TE. Endotoxemia and human liver transplantation. Transplant Proc 1989; 21: 3833-3841.
12. Rao PN, Bronsther OL, Pinna AD et al. Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. Transplant Proc 1993; 25: 2141-2142.
13. Koller J, Wieser C, Furtwanger W, Kornberger R, Konigsrainer A, Margreiter R. Orthotopic liver transplantation and perioperative lactate metabolism. Transplant Proc 1991; 23: 1989-1990.
14. Steininger R, Fugger R, Hackl W et al. Immediate graft function after OLT clears endotoxins. Transplant Proc 1990; 22: 1544-1546.
15. Lamesch P, Ringe B, Oellerich M et al. Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX and GAL tests. Transplant Proc 1990; 22: 1539-1541.
16. Littlefield M, Kalaczowski L, Wang P. Monoethylglycinexylidide determined by fluorescence polarization immuno assay as a liver function test. Clin Chem 1988; 34: 1159.
17. Novros JS, Kock TR, Knoblock EC. Improved method for accurate quantitation of total and conjugated bilirubin in serum. Clin Chem 1979; 25: 1891-1899.
18. Carton EG, Rettke SR, Plevak DJ, Geiger HJ, Kramer PW, Coursin DB. Perioperative care of the liver transplant patient. Anesth Analg 1994; 78: 120-133.
19. Oellerich M, Raude E, Burdelski M et al. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function. J Clin Chem Clin Biochem 1987; 25: 845-853.
20. Burdelski M, Oellerich M, Lamesch P et al. Evaluation of quantitative liver function tests in liver donors. Transplant Proc 1987; 19: 3838-3839.
21. Burdelski M, Oellerich M, Raude et al. A novel approach to assessment of liver function in donors. Transplant Proc 1988; 20: 591-593.
22. Oellerich M, Brudelski M, Ringe B et al. Lignocaine metabolite formation as a measure of pretransplant liver function. Lancet 1989; 25: 640-642.
23. Oellerich M, Burdelski M, Ringe B et al. Functional state of the donor liver and early outcome of transplantation. Transplant Proc 1991; 23: 1575-1578.
24. Oellerich M, Burdelski M, Lantz H-U, Binder L, Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991; 14: 1029-1034.
25. Oellerich M, Burdelski M, Lantz H-U et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991; 51: 801-806.
26. Gremse DA, A-Kader HH, Schroeder TJ, Balistreri WF. Assessment of lidocaine metabolite formation as a quantitative liver function test in children. Hepatology 1990; 12: 565-569.
27. Schroeder TJ, Gremse DA, Mansour ME et al. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Transplant Proc 1989; 21: 2299-2301.
28. Burdelski M, Oellerich M, Bornscheuer A, Luebbe N, Ringe B. Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors. Transplant Proc 1989; 21: 2392-2393.
29. Potter JM, Hiclamn PE, Lynch SV et al. Use of monoethylglycerinexylidide as a liver function test in the liver transplant recipient. Transplantation 1993; 56: 1385-1388.
30. Freys G, Pottecher R, Calon B, Hammel G, Diebolt JR, Boudjema K. Predictive indicators of early postoperative complications after OLT. Eur J Anaesthesiol 1993; 10: 43-44 (abstract).
31. Branch R. Drugs as indicators of hepatic function. Hepatology 1982; 2: 97-105.
32. Stenson RE, Constantino RT, Harrison DC. Interrelationships of hepatic blood flow, cardiac output and blood levels of lidocaine in man. Circulation 1971; 63: 205-211.
33. Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer VA. Lidocaine metabolism in human liver microsomes by cytochrome P450 III A4. Clin Pharmacol Ther 1989; 46: 521-526.
34. Mets B, Hickmann R, Allin R, Van Dyk J, Lotz Z. Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver. Hepatology 1993; 17: 668-676.
35. Balderson GA, Potter JM, Hickman PE, Chen Y, Lynch SV, Strong RW. MEGX as a test of donor liver function. Transplant Proc 1992; 24: 1960-1961.
36. Adam R, Azoulay D, Astarcioglu I et al. Reliability of the MEGX test in the selection of liver grafts. Transplant Proc 1991; 23: 2470-2471.
37. Potter JM, Hickman PE, Baiderson G, Lynch SV, Strong R. Lignocaine metabolism and MEGX production in the liver transplant donor. Transplant Proc 1992; 24: 198-199.
38. Toussaint RM, Coomes M. Role of cytochrome P450 in modulating cyclosporin levels in transplant patients. Transplant Proc 1993; 25: 1980-1982.
39. Wandel C, Bohrer H, Bocker R. Bedeutung der Cytochrom P450 super familie im Metabolismus anästhesierelevanter Pharmaka. Anästhesi{ol Intensivmed Notfallmed Schmerzther 1993; 28: 511-516.
40. Azoulay D, Lemoine A, Gries JM et al. Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient. Transplant Proc 1993; 25: 2275-2278.
41. Azoulay D, Lemoine A, Dennison A et al. Relationship between cytochrome P450 3A content of orthotopically transplanted liver and postoperative morbidity. Transplant Proc 1993; 25: 2630-2631.
42. Lamesch P, Ringe B, Oellerich M, Schuhmann G, Kobes-Krause S, Pichlmayr R. MEGX test in the donor. The influence of the duration of the intensive care for the MEGX test result. Eur J Anaesthesiol 1993; 10: 42-43 (Abstract).
43. Takada Y, Ozawa K, Yamaoka Y et al. Arterial ketone bodyratio and glucose administration as an energy substrate in relation to changes in ketone body concentration after living-related liver transplantation in children. Transplantation 1993; 55: 1314-1319.
44. Asonuma K, Takaya S, Selby R et al. The clinical significance of the arterial ketone bodyratio as an early indicator of graft viability in human liver transplantation. Transplantation 1991; 51: 164-177.
45. Azaoulay D, Lemoine A, Ries JM et al. Lidocaïne metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient. Transplantation Proc 1993; 25: 2225-2278.
46. Toussaint RM, Gommes M. Role of cytochrome P 450 in modulating Cyclosporine. Levels in transplant patients. Transplantation Proc 1993; 25: 1980-1982.
47. Forster J, Greig PD, Glynn MFX et al. Predictors of graft function following liver transplantation. Transplant Proc 1989; 21: 3356-3357.
48. 14] aminopyrine breath test. Transplant Proc 1993; 25: 2640-2641.
49. Gozzo ML, Avolio AW, Colacicco L et al. Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation. Transplant Proc 1993; 25: 1760-1761.
50. Howard TK, Klintmalm GBG, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection on the hepatic transplant recipient. Transplantation 1990; 49: 103-107.